Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Duvall Diantha Insider Profile
4 Followers
Duvall Diantha, CAO at Bioverativ Inc, holds 6.62K shares in Genocea Biosciences (Ticker: GNCA), holds 0.00 shares in Bioverativ Inc (Ticker: BIVV).
Duvall Diantha Bioverativ Inc (BIVV)CAO
Bioverativ Inc (BIVV)
CAO
Not Ranked
Duvall Diantha has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Roles
CFO
Roles that Duvall Diantha holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Duvall Diantha
Duvall Diantha's Trading History
Bioverativ Inc
Mar 08, 2018
―
Uninformative Sell
―
$0.00
Genocea Biosciences
Jun 02, 2020
CFO
Uninformative Buy
―
$13.78K
List of latest transactions for each holding click on a transaction to see Duvall Diantha's performance on stock
You May Also Like
Duvall Diantha insider profile FAQ
What is the percentage of profitable transactions made by Duvall Diantha?
The percentage of profitable transactions made by Duvall Diantha is ―.
What is the average return per transaction made by Duvall Diantha?
The average return per transaction made by Duvall Diantha is ―.
What stocks does Duvall Diantha hold?
Duvall Diantha holds: BIVV, GNCA stocks.
What was Duvall Diantha’s latest transaction?
Duvall Diantha latest transaction was an Uninformative Buy of ―.
What was Duvall Diantha's most profitable transaction?
Duvall Diantha’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Duvall Diantha's role in Bioverativ Inc?
Duvall Diantha's role in Bioverativ Inc is CAO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.